We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Identifying Risk Factors for Progression from Primary Angle Closure Suspect to Primary Angle Closure: Insights from the ANA-LIS Trial

MedXY Editorial Team•Aug 10, 2026•news
anterior segment imagingplateau irisprimary angle closureÁp lực nội nhãn

Highlight

This post hoc analysis of the Singapore Asymptomatic Narrow Angles-Laser Iridotomy Study (ANA-LIS) reveals that higher baseline intraocular pressure (IOP), narrower anterior chamber angles, and the presence of plateau iris configuration in multiple quadrants are significant risk factors for progression from primary angle closure suspect (PACS) to primary angle closure (PAC) over a five-year period. Comprehensive anterior segment imaging techniques such as AS-OCT and ultrasound biomicroscopy (UBM) are instrumental in risk stratification and patient management.

Study Background

Primary angle closure glaucoma (PACG) remains a leading cause of irreversible blindness worldwide, especially in Asian populations. It develops through a pathophysiological sequence beginning with primary angle closure suspect (PACS), characterized by anatomically narrow angles but without elevated intraocular pressure (IOP) or peripheral anterior synechiae, potentially progressing to primary angle closure (PAC) marked by raised IOP or angle closure-related structural changes. Accurate identification of PACS eyes at greatest risk of progression is crucial for timely intervention, such as laser peripheral iridotomy (LPI), to prevent irreversible optic nerve damage and visual loss. However, the factors predictive of disease progression have remained insufficiently characterized, particularly using advanced anterior segment imaging modalities.

Study Design

This study is a post hoc analysis of the ANA-LIS, a randomized clinical trial conducted between 2004 and 2018 across five tertiary eye centers in Singapore. The original trial enrolled 480 participants with PACS, who underwent comprehensive ophthalmic evaluation. Baseline assessments included anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) to quantify angle anatomy and detect plateau iris configuration. One eye per participant was randomly selected for laser peripheral iridotomy (LPI), with the fellow eye serving as control. Progression was defined as development of primary angle closure—manifested by elevated IOP greater than 24 mm Hg, formation of peripheral anterior synechiae (PAS) occupying at least one clock hour, or an acute angle closure episode. Data analysis was conducted from May to July 2025 using generalized linear models and Cox regression models clustered by participant.

Key Findings

Out of 480 participants, 161 underwent baseline AS-OCT and UBM examinations and were included in the current analysis. The cohort was predominantly female (76.4%) with a mean age of 62.9 years. During the 5-year follow-up, 16 of 322 eyes (5.0%) progressed from PACS to PAC. The progression rate was comparable between eyes that received LPI (7 eyes) and those that did not (9 eyes).

Multivariable analysis revealed several independent predictors of progression:

  • Baseline Intraocular Pressure (IOP): Each 1 mm Hg increase in baseline IOP was associated with a 60% increased odds of progression (OR 1.6; 95% CI, 1.2-2.1; P = .003), underscoring the prognostic importance of subtle IOP elevations.
  • Plateau Iris Configuration: Identified by UBM, the presence of plateau iris in multiple quadrants was associated with markedly increased risk. Each additional quadrant with plateau iris raised odds of progression by 4.5-fold (OR 4.5; 95% CI, 1.6-13.0; P = .005). In time-to-event analysis, eyes with plateau iris in at least one quadrant had an 11-fold higher hazard of progression (HR 11.1; 95% CI, 3.3-37.7; P = .001).
  • Anterior Chamber Angle Narrowing: Trabecular-iris space area measured at 750 µm from the scleral spur (TISA750) was inversely related to progression risk. Smaller TISA750 (i.e., narrower angles) were associated with a threefold increase in hazard per 0.1 mm2 decrement (HR 3.1; 95% CI 1.3-7.5; P = .02).

Adjusting for iris curvature did not materially change these associations, affirming the robustness of these anatomical predictors. The model incorporating these factors achieved excellent discriminatory ability with an area under the receiver operating characteristic curve of 0.83.

Expert Commentary

The findings from this analysis emphasize the value of advanced anterior segment imaging modalities in risk stratifying PACS patients. While the role of LPI in preventing progression has been debated, these data highlight that anatomical parameters and subtle IOP elevations should guide clinical decision-making rather than solely relying on gonioscopic angle appearance. Plateau iris, often under-recognized in clinical practice, emerges as a strong indicator of progression risk, particularly when present in multiple quadrants, suggesting that eyes with this configuration might benefit from closer monitoring or alternative interventions such as iridoplasty.

Limitations include the post hoc nature of the analysis and the relatively small number of progression events, which may limit generalizability. Nevertheless, the longitudinal design, rigorous imaging techniques, and multicenter participation strengthen the validity of conclusions.

Conclusion

This post hoc analysis from the ANA-LIS trial demonstrates that higher baseline IOP, narrower anterior chamber angles quantified by TISA750, and presence of plateau iris configuration in multiple quadrants independently increase the risk of progression from PACS to PAC over five years. Incorporating comprehensive anterior segment imaging into routine assessment can improve early identification of high-risk eyes, enabling tailored preventive strategies to curb vision loss from angle closure disease.

Funding and Trial Registration

The original ANA-LIS trial was supported by research grants from multiple ophthalmic research bodies. The trial is registered at ClinicalTrials.gov under identifier NCT00347178.

References

  1. Tun TA, Yoo C, Servillo A, et al. Factors Associated With Progression to Primary Angle Closure: A Post Hoc Analysis of the ANA-LIS Trial. JAMA Ophthalmol. 2026;doi:10.1001/jamaophthalmol.2026.61625.
  2. Qin L, Wang D, He M, et al. Anterior segment OCT and Ultrasound Biomicroscopy in angle-closure glaucoma. Am J Ophthalmol. 2021;223:13-23.
  3. Foster PJ, Buhrmann R, Quigley HA, et al. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238-242.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Long-Term Visual Field Outcomes in Eyes with Failed Trabeculectomy: Evaluating Repeat Trabeculectomy versus Ahmed Glaucoma Valve ImplantationThis retrospective cohort study compares visual field progression after repeat trabeculectomy versus Ahmed glaucoma valve implantation in eyes with prior trabeculectomy failure, revealing similar postoperative visual outcomes but greater inSep 17, 2026IOP Stress Testing Identifies Glaucoma Eyes at Risk of Fast Progression Despite Controlled Office PressureA stress test measuring intraocular pressure identifies glaucoma patients at risk of rapid progression despite normal office pressure readings, offering complementary prognostic insights beyond routine checks.Aug 28, 2026Long-Term Efficacy and Visual Field Outcomes of Selective Laser Trabeculoplasty in Glaucoma ManagementThis study evaluates long-term outcomes of selective laser trabeculoplasty (SLT) in controlling intraocular pressure and preventing visual field deterioration, identifying clinical factors influencing effectiveness and progression risk.Aug 26, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Enhancing Glaucoma Research Accuracy: Contrasting Diagnostic and Treatment-Based Definitions in UK Biobank
This study compares diagnostic-only versus combined diagnostic and treatment-based definitions of glaucoma in UK Biobank participants, revealing stronger associations of risk factors and severity biomarkers with definitions including treatm
Jun 29, 2026
The 22 mm Hg Threshold: Does a Historical Cutoff Still Dictate Modern Glaucoma Management?A multicenter cohort study of 1.8 million clinic encounters reveals that while clinicians view intraocular pressure as a continuous risk factor, the historical 22 mm Hg cutoff remains a significant psychological trigger for escalating glaucJan 17, 2026
Nonmedical Factors Impacting Quality of Care in Newly Diagnosed Primary Open-Angle Glaucoma PatientsThis study reveals that socioeconomic status, residential location, and household composition significantly affect treatment outcomes and follow-up in newly diagnosed POAG patients, highlighting the need for targeted strategies to improve gOct 6, 2025